TuHURA Biosciences HURA
NASDAQ HURA
$2.00 -0.22 (-9.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

TuHURA Biosciences (HURA) Other Non-Current Assets (2020 - 2026)

TuHURA Biosciences (HURA) posted quarterly Other Non-Current Assets of $11.3 million for Q1 2026, up 33288.61% quarter-over-quarter from $33769.0 in Q4 2025.

TuHURA Biosciences (HURA) Other Non-Current Assets (2020 - 2026) Analysis & Trends

TuHURA Biosciences' Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $11.3 million for Q1 2026.

  • In Q1 2026, Other Non-Current Assets changed N/A year-over-year to $11.3 million; the TTM figure through Mar 2026 stood at $11.3 million (changed N/A YoY), while the FY2025 annual figure was $33769.0, changed 0.0% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $11.3 million, up from $33769.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $11.3 million in Q1 2026, with the low at $33769.0 in Q4 2024.
  • The 4-year median for Other Non-Current Assets is $3.4 million (2022), against an average of $4.7 million.
  • The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets jumped 104.76% in 2022, then changed 0.0% in 2025.
  • TuHURA Biosciences' Other Non-Current Assets stood at $4.3 million in 2022, then sank by 99.21% to $33769.0 in 2024, then changed by 0.0% to $33769.0 in 2025, then surged by 33288.61% to $11.3 million in 2026.
  • Business Quant data shows HURA's Other Non-Current Assets at $11.3 million in Q1 2026, $33769.0 in Q4 2025, and $8.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 618.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 109.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 65.13 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 202.31 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 104.44 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 62.96 Mn
10 TuHURA Biosciences 37.61 Mn 37.61 Mn - 11.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.28 Mn
Dec 31, 2025 33,769.00
Sep 30, 2025 8.26 Mn
Jun 30, 2025 8.26 Mn
Dec 31, 2024 33,769.00
Sep 30, 2022 4.30 Mn
Jun 30, 2022 2.60 Mn
Mar 31, 2022 2.60 Mn
Dec 31, 2021 2.60 Mn
Sep 30, 2021 2.10 Mn
Jun 30, 2021 1.60 Mn
Mar 31, 2021 2.10 Mn
Dec 31, 2020 2.60 Mn